Notes and references
- Regulatory Classification of Pharmaceutical Co-Crystals Guidance for Industry, U.S. FDA (2018).
- N. Schultheiss, and A. Newman, Cryst. Growth Des. Growth 9 (6), 2950 (2009). doi:https://doi.org/10.1021/cg900129f
- S. Kumar, and A. Nanda, Indian J. Pharm. Sci. 79 (6), 858 (2017).
- N. Shan et al., Expert Opin. Drug Metab. Toxicol. 10 (9), 1255 (2014). doi:https://doi.org/10.1517/17425255.2014.942281
- A. J. Smith et al., Mol. Pharm. 8 (5), 1867 (2011). doi:https://doi.org/10.1021/mp200209j
- M. Pudipeddi, and A. T. M. Serajuddin, J. Pharm. Sci. 94 (5), 929 (2005). doi:https://doi.org/10.1002/jps.20302
- L. P. Jordheim et al., Nat. Rev. Drug. Discov. 12 (6), 447 (2013). doi:https://doi.org/10.1038/nrd4010
- A. Sarkar, and S. Rohani, J. Pharm. Sci. 104 (1), 98 (2015). doi:https://doi.org/10.1002/jps.24248
- B. A. Witika, V. J. Smith, and R. B. Walker, Crystals 11 (1), 33 (2021). doi:https://doi.org/10.3390/cryst11010033
- D. J. Berry et al., Cryst. Growth Des. 8 (5), 1697 (2008). doi:https://doi.org/10.1021/cg800035w
- K. Shiraki, and T. Daikoku, Pharmacol. Ther. 209, 1–15 (2020).
- O. V. Dolomanov et al., J. Appl. Crystallogr. 42 (2), 339 (2009). doi:https://doi.org/10.1107/S0021889808042726
- G. M. Sheldrick, Struct. Commun. 713, 3–8 (2015).
- M. D. Hanwell et al., J. Cheminform. 4 (1), 17 (2012). doi:https://doi.org/10.1186/1758-2946-4-17
- Avogadro: an open-source molecular builder and visualization tool. Version 1.2.0. http://avogadro.cc/.
- M. Rodrigues et al., Int. J. Pharm. 547 (1–2), 404 (2018). doi:https://doi.org/10.1016/j.ijpharm.2018.06.024
- G. R. Desiraju, Angew. Chem. Int. Ed. Engl. 34 (21), 2311 (1995). doi:https://doi.org/10.1002/anie.199523111
- L. Fabian, Cryst. Growth Des. 9 (3), 1436 (2009).
- K. Takakura et al., inventors; Toyama Chemical Co., Ltd., assignee. Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide. Japan patent WO2012043696A1 (2012).
- MarvinSketch V20.20. 0. ChemAxon, https://chemaxon.com/products/marvin, 2020
- T. A. Halgren, J. Comput. Chem. 17 (5–6), 490 (1996). doi:https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
- T. A. Halgren, J. Comput. Chem. 20 (7), 720 (1999). doi:https://doi.org/10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X
- P. J. Linstrom, and W. G. Mallard, NIST Chemistry WebBook, NIST Standard Reference Database Number 69 (National Institute of Standards and Technology: Gaithersburg MD, 2018).
- R. C. Rowe, P. Sheskey, and M. Quinn, Handbook of Pharmaceutical Excipients, 6th ed. (Libros Digitales-Pharmaceutical Press: London, UK, 2009).
- M. D. Eddleston, N. Madusanka, and W. Jones, J. Pharm. Sci. 103 (9), 2865 (2014). doi:https://doi.org/10.1002/jps.24003
- T. Friščić et al., Cryst. Eng. Commun. 11 (3), 418 (2009). doi:https://doi.org/10.1039/B815174A
- K. Saroj et al., Curr. Org. Synth. 16 (3), 385 (2019).
- F. Shi et al., Drug Discov. Ther. 8 (3), 117 (2014). doi:https://doi.org/10.5582/ddt.2014.01028
- P. P. Nievergelt, and B. Spingler, Cryst. Eng. Commun. 19 (1), 142 (2017). doi:https://doi.org/10.1039/C6CE02222G
- C. F. Macrae et al., J. Appl. Crystallogr. 53 (Pt 1), 226 (2020). doi:https://doi.org/10.1107/S1600576719014092
- S. Gracin, and A. C. Rasmuson, Cryst. Growth Des. 4 (5), 1013 (2004). doi:https://doi.org/10.1021/cg049954h